Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$122.0 - $145.31 $827,526 - $985,637
-6,783 Reduced 40.64%
9,909 $1.28 Million
Q2 2023

Aug 11, 2023

BUY
$122.5 - $147.16 $866,442 - $1.04 Million
7,073 Added 73.53%
16,692 $2.07 Million
Q1 2023

May 12, 2023

BUY
$133.98 - $160.47 $1.29 Million - $1.54 Million
9,619 New
9,619 $1.41 Million
Q2 2022

Aug 11, 2022

BUY
$141.59 - $168.66 $202,898 - $241,689
1,433 New
1,433 $224,000
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $32,288 - $46,382
-251 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$160.2 - $186.42 $40,210 - $46,791
251 New
251 $45 Million
Q2 2020

Aug 14, 2020

SELL
$95.68 - $121.88 $340,046 - $433,161
-3,554 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$87.74 - $152.74 $88,792 - $154,572
1,012 Added 39.81%
3,554 $354,000
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $299,066 - $390,781
2,542 New
2,542 $379,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Fora Capital, LLC Portfolio

Follow Fora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.